EHU012091
MISSION® esiRNA
targeting human DDX24
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TCTCTGGGCTCCTCAAAGTCCTTGATATCATGCCCTTGACCCTGCATGCCTGTATGCACCAGAAGCAGAGGCTCAGAAACCTGGAGCAGTTTGCCCGTCTGGAAGACTGTGTTCTCTTGGCAACAGATGTGGCAGCTCGGGGTCTGGATATTCCTAAAGTCCAGCATGTCATCCATTACCAGGTCCCACGTACCTCGGAGATTTATGTCCACCGAAGTGGTCGAACTGCTCGAGCTACCAATGAAGGCCTCAGTCTGATGCTCATTGGGCCTGAGGATGTGATCAACTTTAAGAAGATTTACAAAACGCTCAAGAAAGATGAGGATATCCCACTGTTCCCCGTGCAGACAAAATACATGGATGTGGTCAAGGAGCGAATCCGTTTAGCTCGACAGATTGAGAAATCTGAGTATCGGAACTTCCAGGCTTG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... DDX24(57062)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
12 - Non Combustible Liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen.
David Oliver et al.
Scientific reports, 7, 43023-43023 (2017-02-23)
Targeted cancer therapeutics aim to exploit tumor-specific, genetic vulnerabilities specifically affecting neoplastic cells without similarly affecting normal cells. Here we performed sequencing-based screening of an shRNA library on a panel of cancer cells of different origins as well as normal
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU012091-50UG | 04061828448487 |
| EHU012091-20UG | 04061828674084 |